Cussenot O, Valeri A, Meria P, Berthon P, Fournier G, Teillac P, Le Duc A
Service d'Urologie, Hôpital Saint-Louis, Paris, France.
Pathol Biol (Paris). 1996 Oct;44(8):737-43.
The incidence of clinical prostate cancer varies across countries and ethnic groups. Genetic and epigenetic factors have been suggested as possible explanations to these variations, although no mesological factors with clearly significant effects have been identified. About 20% of patients with prostate cancer have a family history for this disease. Several studies have reported links between prostate cancer and breast cancer, suggesting that the same loci may predispose to both diseases. Identification of one or more inherited genes associated with an increased risk of prostate cancer in some families may be useful for identifying high-risk individuals. The value of this approach has been demonstrated in other familial cancers, such as colon and breast cancer. Current goals of research in this field are to localize the gene(s) that predispose to familial prostate cancer and to identify the molecular alterations related to tumor progression in sporadic and familial prostate cancer.
临床前列腺癌的发病率在不同国家和种族群体中有所不同。遗传和表观遗传因素被认为可能是这些差异的原因,尽管尚未确定有明显显著影响的中介因素。约20%的前列腺癌患者有该病的家族史。多项研究报告了前列腺癌与乳腺癌之间的联系,表明相同的基因座可能使个体易患这两种疾病。在一些家族中鉴定出一个或多个与前列腺癌风险增加相关的遗传基因,可能有助于识别高危个体。这种方法的价值已在其他家族性癌症(如结肠癌和乳腺癌)中得到证明。该领域目前的研究目标是定位导致家族性前列腺癌的基因,并确定散发性和家族性前列腺癌中与肿瘤进展相关的分子改变。